Tag:#Brains Bioceuticals

UK Companies Warn Ban On Medical Cannabis Exports Will Damage Future Investment

AS Brains Bioceuticals unveiled a significant expansion of its UK production facilities, it has warned that any future investment is under threat unless the...

Securing Novel Foods Validation is a Highly Rigorous Process That is Both Costly and Time-Consuming for Companies

As the European Commission begins to release updates on CBD products that have made it through to the final stage of the Novel Food process, Dean Billington of Brains Bioceutical reflects on the impact of this lengthy process.

Markets: US Stocks Surge With Democrats’ Victory, Columbia Care, Sativa Wellness, Cann Group et al…

WITH the Democrats in control of the White House, Senate and Congress Wall Street now beckons for America's cannabis industry. Stock prices moved ahead rapidly...

UK CBD Company Brains Preparing For A Future Of Patented Cannabis Medicines

THE comings and goings over the status of CBD as a food or a drug is no longer academic as recent events in Europe...

Latest news

Tetra Pharm Technologies Secures €9 Million In Series A Round To Expand R&D Operations

PRESS RELEASE THE Scandinavian Biotech company, Tetra Pharm Technologies has secured €9M in a series A round led by a...
- Advertisement -spot_imgspot_img

European Cannabis Stocks Review: OCT Shares Fall As Co-Founder Divests, Cannabis Poland Secures Funding, & Akanda’s Legal Battle Continues

Oxford Cannabinoid Technologies  THE pharmaceutical cannabis company has seen its shares drop around 25% this week, following weeks of the...

European Round-Up: France’s CESE Calls For End To ‘Bitter Failure’ Of Cannabis Prohibition, Clever Leaves and Tilray Slash Portuguese Operations, & More From Czechia...

FRANCE’s Economic, Social and Environmental Council (CESE) has released a ‘draft opinion’ calling for the legalisation of cannabis.  On Tuesday,...

Must read